134 related articles for article (PubMed ID: 2174642)
21. Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens.
Schwartz H; Krause R; Sahba B; Haber M; Weissfeld A; Rose P; Siepman N; Freston J
Am J Gastroenterol; 1998 Apr; 93(4):584-90. PubMed ID: 9576452
[TBL] [Abstract][Full Text] [Related]
22. Therapy of H. pylori infection.
Bazzoli F; Pozzato P
J Physiol Pharmacol; 1997 Sep; 48 Suppl 4():39-46. PubMed ID: 9440054
[TBL] [Abstract][Full Text] [Related]
23. The importance of the level of metronidazole resistance for the success of Helicobacter pylori eradication.
Wheeldon TU; Granström M; Hoang TT; Phuncarg DC; Nilsson LE; Sörberg M
Aliment Pharmacol Ther; 2004 Jun; 19(12):1315-21. PubMed ID: 15191514
[TBL] [Abstract][Full Text] [Related]
24. [Eradication of metronidazole-resistant Helicobacter pylori: is omeprazole/amoxicillin a therapeutic alternative?].
Zala G; Wirth HP; Bauer S; Wüst J; Flury R; Meyenberger C; Ammann R
Schweiz Med Wochenschr; 1994 Aug; 124(31-32):1385-90. PubMed ID: 8091166
[TBL] [Abstract][Full Text] [Related]
25. [Effectiveness of triple therapy to eradicate H. pylori in patients after failed therapy with omeprazole/amoxicillin].
Zala G; Schwery S; Giezendanner S; Flury R; Wüst J; Meyenberger C; Wirth HP
Schweiz Med Wochenschr; 1996 Feb; 126(5):153-8. PubMed ID: 8685685
[TBL] [Abstract][Full Text] [Related]
26. Anti-Helicobacter pylori treatment in bleeding ulcers: randomized controlled trial comparing 2-day versus 7-day bismuth quadruple therapy.
Kung NN; Sung JJ; Yuen NW; Ng PW; Wong KC; Chung EC; Lim BH; Choi CH; Li TH; Ma HC; Kwok SP
Am J Gastroenterol; 1997 Mar; 92(3):438-41. PubMed ID: 9068464
[TBL] [Abstract][Full Text] [Related]
27. Guidelines for the treatment of Helicobacter pylori in the pediatric population.
Robinson DM; Abdel-Rahman SM; Nahata MC
Ann Pharmacother; 1997 Oct; 31(10):1247-9. PubMed ID: 9337451
[TBL] [Abstract][Full Text] [Related]
28. Clarithromycin for treatment of Helicobacter pylori infections.
Graham DY
Eur J Gastroenterol Hepatol; 1995 Aug; 7 Suppl 1():S55-8. PubMed ID: 8574737
[TBL] [Abstract][Full Text] [Related]
29. Effect of lansoprazole on Helicobacter pylori.
Lamouliatte H
Clin Ther; 1993; 15 Suppl B():32-6. PubMed ID: 8205593
[TBL] [Abstract][Full Text] [Related]
30. The effect of culture results for Helicobacter pylori on the choice of treatment following failure of initial eradication.
Avidan B; Melzer E; Keller N; Bar-Meir S
Isr Med Assoc J; 2001 Mar; 3(3):163-5. PubMed ID: 11303370
[TBL] [Abstract][Full Text] [Related]
31. [Helicobacter pylori resistance].
Alimoradi J; Rasmussen L; Andersen LP
Ugeskr Laeger; 2010 May; 172(20):1516-21. PubMed ID: 20483098
[TBL] [Abstract][Full Text] [Related]
32. Helicobacter pylori and antimicrobial resistance: molecular mechanisms and clinical implications.
Gerrits MM; van Vliet AH; Kuipers EJ; Kusters JG
Lancet Infect Dis; 2006 Nov; 6(11):699-709. PubMed ID: 17067919
[TBL] [Abstract][Full Text] [Related]
33. Resistance of Helicobacter pylori to antibiotics.
Mégraud F
Aliment Pharmacol Ther; 1997 Apr; 11 Suppl 1():43-53. PubMed ID: 9146790
[TBL] [Abstract][Full Text] [Related]
34. Twelve year observation of primary and secondary antibiotic-resistant Helicobacter pylori strains in children.
Bontems P; Devaster JM; Corvaglia L; Dezsöfi A; Van Den Borre C; Goutier S; Butzler JP; Cadranel S
Pediatr Infect Dis J; 2001 Nov; 20(11):1033-8. PubMed ID: 11734707
[TBL] [Abstract][Full Text] [Related]
35. Will Helicobacter pylori be the next organism for which we will have exhausted our treatment options?
Hazell SL
Eur J Clin Microbiol Infect Dis; 1999 Feb; 18(2):83-6. PubMed ID: 10219573
[No Abstract] [Full Text] [Related]
36. New strategies for the prevention and treatment of Helicobacter pylori infection.
Ruggiero P; Peppoloni S; Berti D; Rappuoli R; Giudice GD
Expert Opin Investig Drugs; 2002 Aug; 11(8):1127-38. PubMed ID: 12150706
[TBL] [Abstract][Full Text] [Related]
37. Review article: nitroimidazole resistance in Helicobacter pylori.
Van Der Wouden EJ; Thijs JC; Van Zwet AA; Kleibeuker JH
Aliment Pharmacol Ther; 2000 Jan; 14(1):7-14. PubMed ID: 10632640
[TBL] [Abstract][Full Text] [Related]
38. Engineering bioinspired bacteria-adhesive clay nanoparticles with a membrane-disruptive property for the treatment of Helicobacter pylori infection.
Ping Y; Hu X; Yao Q; Hu Q; Amini S; Miserez A; Tang G
Nanoscale; 2016 Sep; 8(36):16486-98. PubMed ID: 27605059
[TBL] [Abstract][Full Text] [Related]
39. Mechanism of antibacterial activity of liposomal linolenic acid against Helicobacter pylori.
Jung SW; Thamphiwatana S; Zhang L; Obonyo M
PLoS One; 2015; 10(3):e0116519. PubMed ID: 25793403
[TBL] [Abstract][Full Text] [Related]
40. Chemoselective coupling reactions of 5,7-dimethoxyphthalide with the remotely functionalized alkyl iodides: facile racemic synthesis of Helicobacter pylori antibiotics.
Singh M; Argade NP
J Org Chem; 2010 May; 75(9):3121-4. PubMed ID: 20377262
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
